Follow
Flemming Skjøth
Flemming Skjøth
Verified email at rn.dk
Title
Cited by
Cited by
Year
Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study
TB Larsen, LH Rasmussen, F Skjøth, KM Due, T Callréus, M Rosenzweig, ...
Journal of the American College of Cardiology 61 (22), 2264-2273, 2013
5682013
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
TB Larsen, F Skjøth, PB Nielsen, JN Kjældgaard, GYH Lip
bmj 353, 2016
5132016
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
GYH Lip, TB Larsen, F Skjøth, LH Rasmussen
Journal of the American College of Cardiology 60 (8), 738-746, 2012
4072012
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
PB Nielsen, F Skjøth, M Søgaard, JN Kjældgaard, GYH Lip, TB Larsen
bmj 356, 2017
3872017
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
DA Lane, F Skjøth, GYH Lip, TB Larsen, D Kotecha
Journal of the American Heart Association 6 (5), e005155, 2017
2902017
Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide …
PB Nielsen, TB Larsen, F Skjøth, A Gorst-Rasmussen, LH Rasmussen, ...
Circulation 132 (6), 517-525, 2015
2842015
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score
GYH Lip, F Skjøth, LH Rasmussen, TB Larsen
Journal of the American College of Cardiology 65 (14), 1385-1394, 2015
2112015
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
PB Nielsen, F Skjøth, TF Overvad, TB Larsen, GYH Lip
Circulation 137 (8), 832-840, 2018
1982018
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
A Gorst‐Rasmussen, F Skjøth, TB Larsen, LH Rasmussen, GYH Lip, ...
Journal of Thrombosis and Haemostasis 13 (4), 495-504, 2015
1882015
Effects of varying content of soluble dietary fibre from wheat flour and oat milling fractions on gastric emptying in pigs
HN Johansen, KEB Knudsen, B Sandström, F Skjøth
British journal of nutrition 75 (3), 339-351, 1996
1771996
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
LH Rasmussen, TB Larsen, T Graungaard, F Skjøth, GYH Lip
Bmj 345, 2012
1742012
Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation
TB Larsen, A Gorst-Rasmussen, LH Rasmussen, F Skjøth, M Rosenzweig, ...
The American journal of medicine 127 (7), 650-656. e5, 2014
1522014
Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study
J Bodilsen, PB Nielsen, M Søgaard, M Dalager-Pedersen, LOZ Speiser, ...
Bmj 373, 2021
1452021
Body mass index and adverse events in patients with incident atrial fibrillation
TF Overvad, LH Rasmussen, F Skjøth, K Overvad, GYH Lip, TB Larsen
The American journal of medicine 126 (7), 640. e9-640. e17, 2013
1352013
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score
GYH Lip, F Skjøth, PB Nielsen, TB Larsen
Thrombosis and haemostasis 114 (10), 826-834, 2015
1242015
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
F Skjøth, TB Larsen, LH Rasmussen, GYH Lip
Thrombosis and haemostasis 112 (05), 981-988, 2014
1242014
Quantifying and characterizing behavior in dairy calves using the IceTag automatic recording device
P Trénel, MB Jensen, EL Decker, F Skjøth
Journal of dairy science 92 (7), 3397-3401, 2009
1172009
Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study
TF Overvad, F Skjøth, GYH Lip, DA Lane, IE Albertsen, LH Rasmussen, ...
Stroke 46 (8), 2168-2174, 2015
1062015
Myocardial ischemic events in ‘real world’patients with atrial fibrillation treated with dabigatran or warfarin
TB Larsen, LH Rasmussen, A Gorst-Rasmussen, F Skjøth, M Rosenzweig, ...
The American journal of medicine 127 (4), 329-336. e4, 2014
1012014
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: a nationwide cohort study
PB Nielsen, TB Larsen, F Skjøth, TF Overvad, GYH Lip
Scientific reports 6 (1), 27410, 2016
972016
The system can't perform the operation now. Try again later.
Articles 1–20